Clinical trial
Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine…
NCT00192283 · MedImmune LLC, Industry · Completed
Key facts
| NCT number | NCT00192283 |
|---|---|
| Title | Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers |
| Official title | A Prospective, Randomized, Double-Blind, Placebo-Controlled, Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) in Healthy Children Attending Day Care Centers |
| Lead sponsor | MedImmune LLC, Industry |
| Collaborators | Wyeth is now a wholly owned subsidiary of Pfizer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological, Other |
| Interventions | CAIV-T, Placebo |
| Enrollment | 2,903 |
| Start date | Sep 1, 2000 |
| Primary completion | Apr 1, 2002 |
| Completion | May 1, 2002 |
| First posted | Sep 19, 2005 |
| Last update posted | Apr 10, 2009 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: